Tuberculosis 2: Different Faces Of TB Flashcards

1
Q

Route of transmission

A

Airborne: inhalation of mycobacteria into lungs

Others (very rare):
- Inoculation
- Oral
- Organ transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Infection vs Disease

A
  • Only 10% TB infected people will develop disease
  • Half develop disease within first 2 years of infection
  • Depends on balance between host defence and virulence / quantity of mycobacteria

Progression:
Inhalation of MTB
—> Immediate killing of MTB / **Host-TB interaction: Primary complex
——> **
Localised disease (Primary TB)
——> Dissemination of TB —> **Active disease / Containment (Latency) —> Reactivation
——> Containment (Latency) —> **
Reactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Life cycle of TB

A

Entry
—> Multiplication in unique niche
—> **Infection of macrophages
—> Expansion in **
innate granuloma
—> Granuloma maturation with **lymphocytes
—> Granuloma necrosis with **
extracellular replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

***Type 4 Delayed type hypersensitivity

A

Delayed type: 1-2 days after antigen exposure

Mediator: T helper cell (Th1): IFNγ, IL-12 (Major effector mechanism against facultative intracellular pathogens)

Effector: Cell-mediated inflammatory response + macrophage + CD8 T cell

  1. Sensitisation phase:
    APC (dendritic cells / Langerhans cells) —> CD4 T helper —> Th1
  2. Effector phase:
    Sensitised Th1 —> IFNγ, IL-12
    —> activate macrophage + CD8 T cell
    —> ↑ Class II MHC, TNF receptor, oxygen radicals, Nitric oxide

Example:
1. Allergic contact dermatitis (poison ivy, latex)
Re-exposure —> rapid recruitment of macrophage + CD8
—> inflammatory infiltration + local oedema + erythema

  1. Granulomatous hypersensitivity (Tuberculosis)
    - Granuloma: Caseous necrosis (with persistent pathogen) surrounded by Epitheloid macrophage, Langhans giant cells, T Lymphocytes (Th1), Fibroblast
  • Dendritic cell carry Mtb antigen + IL-12 production —> activate Th1 —> IFNγ
    —> activate macrophage —> cannot kill mycobacteria and contain the infection
    —> Infected macrophage continue to present Mtb antigen to Th1 —> IFNγ
    —> activate macrophage —> infected macrophage
    —> chronic inflammation (vicious cycle)
    —> granuloma formation
    —> Chronic localised delayed-type hypersensitivity / Cell-mediated inflammation

Other example: Leprosy, Sarcoidosis , Crohn’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Host risk factors

A
  1. Genetic
  2. Extremes of age
  3. Pregnancy
  4. Smoking
  5. Alcohol
  6. Malnutrition
  7. Socioeconomic
    - stress
    - poverty
    - drug addicts
  8. ***Concurrent diseases
    - DM
    - Renal
    - Silicosis
    - Post gastrectomy
    - HIV
    - Cancer and chemotherapy
    - Haemic malignancy
    - Bone marrow / Solid organ transplant
  9. ***Immunosuppression
    - Steroid
    - Post organ transplant
    - Treatment of autoimmune disease
    - Biologics
    - Chemotherapy for malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Pulmonary TB
A

Common symptoms
1. **Prolonged cough
2. **
Sputum
3. **Haemoptysis
4. **
Fever
5. ***Nightsweat
6. Weight loss
7. SOB
8. Asymptomatic —> only found during health check
9. ARDS-like (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

***2. Extrapulmonary TB

A
  1. LN
  2. Pleura
  3. Abdomen
  4. Others

Diagnosis is difficult:
- Usual presentation: Fever + Abnormal radiological / physical findings
- TST / IGRA: not sensitive / specific for diagnosis
- specimens usually hard to obtain (e.g. pleural fluid, ascitic fluid, CSF)

Diagnosis:
1. High index of suspicion
2. **Microbiology examination (e.g. urine, pleural fluid, CSF)
3. **
Histological (+/- Microbiological) examination —> Granulomatous inflammation +/- Positive ZN stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Pleural TB
A

Breakdown of sub-pleural TB foci into pleural space
—> Inflammatory response
—> ***Pleural effusion

Associated with pulmonary TB

Diagnosis:
1. Pleural fluid
- **Exudation (Protein >0.5, LDH >0.6), **Lymphocyte predominant
- AFB D/S: negative
- AFB culture: positive <1/3
- Adenosine deaminase (ADA)

  1. Pleural biopsy
    - closed pleural biopsy (Abraham needle)
    - pleuroscopy + biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. TB Lymphadenitis
A
  • mainly in ***Cervical region
  • children / young adult
  • gradual ***painless enlargement of cervical LN over weeks to months
  • overlying skin intact in early stage —> shiny + thin —> pink / red + warm
  • initially firm —> ***fluctuant (abscess formation) —> drain out via breakage of overlying skin
  • no systemic symptoms usually
  • abscess formation while on treatment does ***not imply treatment failure —> TB LN are usually pauci-bacillary —> abscess formation is due to heightened inflammatory response to disrupted mycobacterial antigens released from dead bacilli during treatment

DDx:
- Metastatic LN (e.g. NPC)
- Lymphoma

Diagnosis:
1. ***Demonstration of MTB in LN aspirate (Definitive)
2. +ve TST
3. +ve AFB smear in 20-60%, culture +ve 36-70%
4. Histology: Granuloma with caseous necrosis +/- stainable AFB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. TB meningitis
A
  • potential mortality + morbidity
  • permanent neurological deficits for paediatric patients in old days

Symptoms:
1. Headache
2. Impaired conscious state
3. Fever
4. Focal neurological deficit
5. Convulsion

MRC Stages:
- Stage 1: non-specific symptoms without changes in consciousness
- Stage 2: **disturbed consciousness but not yet comatose / delirious, focal neurological signs
- Stage 3: **
stupors / coma with / without focal neurological signs

Diagnosis:
1. Imaging CT / MRI
2. LP: High opening pressure
3. **CSF
- **
high protein
- **low glucose
- **
lymphocytic pleocytosis (PMN in early stage)
- AFB D/S
- AFB culture
- TB-PCR

Management:
1. Anti-TB treatment

  1. Steroid (adjunct)
    - ***prevent ICP ↑
    - ↓ late sequalae from scarring of meninges
    - for stage 2 and 3
  2. Surgical intervention
    - drainage of **obstructive hydrocephalus (early / late)
    - excision + debulking of **
    tuberculoma
    - biopsy for diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Miliary TB
A
  • Widespread of TB by ***haematogenous route —> all organs involved
  • Tiny ***millet-like shadowing on CXR (classical radiological feature) (DDx: Lymphangitis carcinomatosis (SpC Medicine))

Symptoms:
1. Non-specific
2. Fever, lethargy, weight loss
3. Cough

Diagnosis:
1. Sputum for AFB D/S usually **negative
2. Early morning urine (EMU) for urinary involvement
3. **
Biopsy / Histology of involved organs (Definitive)

Management:
- Start treatment based on clinical and radiological features
- watch out for other organ involvement (e.g. CNS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Female Genital TB
A

Insidious and mild
- Pain
- Menstrual irregularities
- Pelvic mass
- Ascites
- CXR normal
- Infertility common

  • Great mimic of ***gynae malignancy
  • ***CA 125 (tumour marker for CA ovary) also ↑
  • High index of suspicion

Diagnosis:
1. **Endometrial aspirate for AFB culture
2. **
Biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Male Genital TB
A

Insidious and mild
- Scrotal swelling
- Dysuria
- Sterile pyuria
- ***Haematuria (Haemospermia)
- Subfertility / Infertility (Presentation / Complication)

High index of suspicion

Diagnosis:
1. **EMU for AFB culture + TB-PCR
2. **
Semen for AFB culture + TB-PCR
3. ***Biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Cutaneous TB
A
  1. TB verrucosa cutis
    - direct inoculation of TB into skin
    - ***purplish / brownish-red warty growth
    - knees, elbows, hands, feet, buttocks
  2. Lupus vulgaris
    - persistent and progressive
    - face
  3. Scrofuloderma
    - extension of underlying TB LN, bone / joint (pointing abscess)
  4. Miliary TB abscessus
    - micro TB abscessus from haematogenous spread
  5. Tuberculid
    - strongly positive tuberculin skin tests
    - erythema induratum (Bazin disease)
    - papulonecrotic tuberculid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Other extra-pulmonary TB
A
  1. Kidneys, bladder
  2. Gut
  3. Bone and joints
  4. Spine
  5. Larynx
  6. Nasopharynx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TB in elderly

A
  1. ***Decline in cell-mediated immunity
  2. ***Comorbidities
  3. ***Socio-economically deprived
  4. More smokers
  5. Environmental factors e.g. living environment, OAH

Difference in presentation:
- lower body weight
- **less haemoptysis
- **
more non-specific complaints e.g. malaise, dyspnea
- lower serum albumin
- **less upper lobe infiltration
- **
more extensive infiltration + lower zone involvement of both lungs

17
Q

Cryptic / Miliary TB in elderly

A
  • Insidious onset + ***non-specific symptoms
  • miliary shadowing may ***not be obvious on CXR
  • ***sputum AFB -ve
  • ***TST -ve (∵ decline in cell-mediated immunity)
  • often delayed / missed diagnosis (misdiagnosed as comorbidities / occult tumour)
  • very poor outcome: 80% mortality

Diagnosis:
- **Bone marrow
- **
Liver biopsy
- bacteriological investigation little help

TB:
- consider in all cases of pyrexia of ***unknown origin (PUO)
- perform investigations to establish / exclude diagnosis
- prompt trial of anti-TB treatment without definite evidence can be life-saving

18
Q

TB in very young (<5)

A

Very rare

Challenges:
1. ***Extra-pulmonary common
—> peripheral LN
—> meningitis
—> pleural effusion
—> miliary
2. Non-specific S/S
3. Difficult to obtain good quality specimens for TB exam

Presenting features:
- TB contact
- Persistent cough
- Persistent fever
- Failure to thrive
- Other symptoms specific for extra-pulmonary TB

19
Q

TB in immunocompromised

A
  • Different presentation
  • may be extrapulmonary
  • ***TST may be -ve
  • need ***high index of suspicion
  • ***early bronchoscopy for respiratory specimen for AFB

Challenges in management:
1. ***Many medications
- Anti-TB + immunosuppressants

  1. Potential drug interaction
    - Rifampicin: ***enzyme inducer
  2. Additive drug toxicity
    - liver, renal, bone marrow
  3. Changes in primary disease course / management
    - ***IRIS (Immune Reconstitution Inflammatory Syndrome) from changes in immune status of patient
    - need for isolation
20
Q

TB from transplantation

A
  1. Endogenous reactivation
  2. Donor-derived reactivation (Donor有TB)
  3. De novo infection
  4. Pre-transplant active TB
21
Q

TB in HIV

A

Bi-directional interaction:
- HIV —> ↓ Immunity —> **TB reactivation —> rapid progression of TB
- TB lesions —> ↑ Pro-inflammatory cytokines (TNFα) —> **
↑ HIV viraemia —> accelerate HIV

Chance of transmission of TB from HIV-infected subjects to non-HIV contacts

Symptoms:
- Fever
- Weight loss
- Cough

Early stage (CD4+ >200) (~ to immunocompetent subjects):
- Haemoptysis
- Upper zone lesions with cavitation

Severely immunocompromised:
- Seldom haemoptysis
- **No zonal predominance
- **
No cavitation
- ***More extrapulmonary disease (haematogenous dissemination): LN, abdomen, CNS, pleura

TST: ***negative in severe immunocompromised

22
Q

Anti-TNF biologics

A

TNF: important mediator for maintenance of granuloma in containing TB infection

Anti-TNF: very high risk of TB development

Usage:
- ***Isoniazid chemoprophylaxis for 9 months for patients with latent TB (Positive TST / IGRA)
- Screen for active + latent TB before using Anti-TNF
- Active TB should be treated adequately before reconsideration of Anti-TNF

23
Q

NTM (Non-Tuberculous Mycobacteria)

A
  • Ubiquitous
  • Survive in wide range of pH and Temp
  • Resistance to chlorine and biocides
  • Escape filtration
  • Infection only from **environmental sources —> **NO human-to-human / animal-to-human i.e. ***NOT infectious
24
Q

NTM infections

A

Only some strains and in only some people

  1. Virulence
    - differs widely
  2. Host factors
    - host immunity
    - underlying lung disease
    - esophageal motility disorders
    - body morphotype

Distinguish from TB:
- **Negative TB-PCR
- **
Molecular diagnosis e.g. gene sequencing

  1. Pulmonary
    - MAC (Mycobacterium Avian Complex)
    - M. kansaii
    —> Infection in previously damaged lungs
    —> Primary lung disease in middle aged and elderly
    —> Hypersensitivity like disease
    —> Lung infection in immunocompromised patient
  2. Disseminated
    - MAC
    - M. abscessus
  3. Skin / soft tissue
    - M. marinum
    - M. ulcerans
  4. LN
    - MAC
    - M. scrofulaceum
25
Q

NTM: Infection in previously damaged lungs

A
  • Non-specific respiratory + constitutional symptoms
  • CXR: progressive worsening: Cavitation, Consolidation, Nodules, Pleural reactions
26
Q

NTM: Primary lung disease in middle aged and elderly

A
  • No pre-existing diseased / scarred lung
  • Chronic cough + Sputum
  • CXR: Nodular shadowing at ***Mid + Lower zones
  • CT thorax: characteristic small airway inflammation in form of **centrilobular nodules (tree-in-bud appearance) and associated **bronchiectasis
27
Q

NTM: Hypersensitivity like disease

A
  • ***Hypersensitive pneumonitis with allergic type of host response to NTM
  • “Hot tub lung” from inhaling mycobacteria in indoor spa, bath
  • Subacute onset of cough, SOB, fever
  • Respiratory failure in severe cases
  • CXR: Non-specific infiltrate + nodules
  • CT thorax: Ground-glass Opacification (GGO) + ***Mosaic pattern apart from nodules + consolidations
28
Q

NTM: Lung infection in immunocompromised patient

A
  • Non-specific respiratory symptoms / Constitutional symptoms
  • Non-specific radiograph: Consolidation, GGO, Nodules, Cavities
  • May have mycobacteriaemia
  • Great diagnostic challenge
29
Q

Anti-MAC treatment

A
  1. Amikicin
  2. Rifampicin
  3. Ethambutol
  4. Clarithromycin